| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 02/06/2007 | CA2286472C Multiparticulate pharmaceutical form, particles constituting it, method and plant for making same |
| 02/06/2007 | CA2232152C Bioadhesive solid dosage form |
| 02/06/2007 | CA2207077C Cross-linked microparticles and their use as therapeutic vehicles |
| 02/06/2007 | CA2203367C Foamable formulation and foam |
| 02/02/2007 | WO2007019845A2 Method for encapsulating therapeutic substances in cells |
| 02/02/2007 | CA2619278A1 Method for encapsulating therapeutic substances in cells |
| 02/01/2007 | WO2007014393A2 Amorphous efavirenz and the production thereof |
| 02/01/2007 | WO2007014392A2 Benzoquinones of enhanced bioavailability |
| 02/01/2007 | WO2007014210A2 Compositions and methods for the reduction of post-operative pain |
| 02/01/2007 | WO2007014134A2 Tandem cardiac pacemaker system |
| 02/01/2007 | WO2007014124A2 High drug load formulations and dosage forms |
| 02/01/2007 | WO2007014113A2 Self-assembled, micropatterned, and radio frequency (rf) shielded biocontainers |
| 02/01/2007 | WO2007014084A1 Oral drug compliance monitoring using sound detection |
| 02/01/2007 | WO2007014061A2 Coated tables with zero-order or near zero-order release kinetics |
| 02/01/2007 | WO2007013975A2 Composition containing an opioid agonist and a partial opioid agonist, preferably buprenorphine , for controlling abuse of medications |
| 02/01/2007 | WO2007013794A1 Ph-controlled pulsatile delivery system, methods for preparation and use thereof |
| 02/01/2007 | WO2007013752A1 Processes for preparing spherical pancreatin-containing granules |
| 02/01/2007 | WO2007013661A1 Percutaneously absorbable ophthalmic preparation |
| 02/01/2007 | WO2007013600A1 Neutron capture preparation and use thereof |
| 02/01/2007 | WO2007013591A1 Non-invasive drug delivery system targeting posterior eye tissue using gel composition |
| 02/01/2007 | WO2007013590A1 Non-invasive drug delivery system targeting posterior eye tissue using solid composition |
| 02/01/2007 | WO2007013494A1 Drug containing phosphate ion as blood glucose level-controlling agent |
| 02/01/2007 | WO2007013490A1 Aqueous solution preparation containing camptothecins |
| 02/01/2007 | WO2007013477A1 Pharmaceutical composition comprising 2 , 3-dihydro-6-nitroimidazo [2 , 1-b] oxazole derivatives |
| 02/01/2007 | WO2007013452A1 Sterilizer selective to cariogenic bacterium, and method for sterilization of cariogenic bacterium |
| 02/01/2007 | WO2007013100A1 Gel formulation comprising platelet derived growth factor |
| 02/01/2007 | WO2007012974A2 Cyclodextrin nanotechnology for ophthalmic drug delivery |
| 02/01/2007 | WO2007012963A1 Transdermal system for varenicline |
| 02/01/2007 | WO2007012960A1 Pharmaceutical compositions of eplerenone |
| 02/01/2007 | WO2007012876A1 Hydrogel particle |
| 02/01/2007 | WO2007012837A2 Compositions for treating psychiatric conditions |
| 02/01/2007 | WO2007012645A1 Novel lasek laser eye surgery |
| 02/01/2007 | WO2007012625A1 Sterile, drop-forming, multi-phase, emulsifier-free ophthalmic product |
| 02/01/2007 | WO2007012478A2 Encapsulation of lipid-based formulations in enteric polymers |
| 02/01/2007 | WO2007012439A1 Pharmaceutical compositions comprising levetiracetam and process for their preparation |
| 02/01/2007 | WO2007012276A1 A medicine for abstaining from addiction to drugs and process thereof |
| 02/01/2007 | WO2007012191A1 Systems and methods for manufacturing liposomes |
| 02/01/2007 | WO2007012154A1 Pharmaceutical preparation containing an acetylcholinesterase ihibitor and an antidepressant with 5-ht and alpha-2-adrenoceptor blocking properties. |
| 02/01/2007 | WO2006133354A3 Methods for producing nanoparticulate metal complexes and altering nanoparticle morphology |
| 02/01/2007 | WO2006122158A3 Skin care compositions containing xanthones |
| 02/01/2007 | WO2006117228A3 Ophthalmic devices for sustained delivery of active compounds |
| 02/01/2007 | WO2006115414A9 Device for preparing a drink |
| 02/01/2007 | WO2006108405A3 Nanoparticle/active ingredient conjugate |
| 02/01/2007 | WO2006095363B1 Injectable preparations of diclofenic and its pharmaceutically acceptable salts |
| 02/01/2007 | WO2006094808A3 Method for producing ultrafine submicronic suspensions |
| 02/01/2007 | WO2006091229A3 Methods of modulating intracellular degradation rates of toxins |
| 02/01/2007 | WO2006088814A3 Dosage form and method for sustained release of a substituted pyrazine compound |
| 02/01/2007 | WO2006088473A3 Microcapsules and nanocapsules for the transmucosal delivery of therapeutic and diagnostic agents |
| 02/01/2007 | WO2006065529A3 Compositions comprising polymeric emulsifiers and methods of using same |
| 02/01/2007 | WO2006055854A3 Methods for reducing the side effects associated with mirtazapine treatment |
| 02/01/2007 | WO2006047693A3 Dosage forms having a microreliefed surface and methods and apparatus for their production |
| 02/01/2007 | WO2006047692A3 Dosage forms having a microreliefed surface and methods and apparatus for their production |
| 02/01/2007 | WO2006047690A3 Dosage forms having a microreliefed surface and methods and apparatus for their production |
| 02/01/2007 | WO2006045056A3 Flavonoid composition for treating oral diseases |
| 02/01/2007 | WO2006037948B1 Methods and kits for delivering drugs by nebulisation |
| 02/01/2007 | WO2006014930A3 Treatment of pulmonary hypertension by inhaled iloprost with a microparticle formulation |
| 02/01/2007 | WO2006012146A3 Pharmaceutical compositions for drug delivery and methods of treating or preventing conditions using same |
| 02/01/2007 | WO2006004719A3 Methods and compositions for the treatment of attention deficit hyperactivity disorder and hyperphenylalanemia |
| 02/01/2007 | WO2005099621A3 Topographic coatings and coating methods for medical devices |
| 02/01/2007 | WO2005072334A3 Photoresponsive hydrogels |
| 02/01/2007 | WO2005058332A3 Edestin-comprising agent for substitution of blood plasma and a method of its production |
| 02/01/2007 | WO2005023219A3 Method for the production of homogeneous liposomes and lipoplexes |
| 02/01/2007 | US20070027382 System for monitoring of patients |
| 02/01/2007 | US20070027098 Immunostimulatory oligonucleotides, compositions thereof and methods of use thereof |
| 02/01/2007 | US20070027085 Microencapsulation and sustained release of biologically active polypeptides |
| 02/01/2007 | US20070027072 Pharmaceutical compositions comprising cyclosporins |
| 02/01/2007 | US20070026515 Cell or drug encapsulation device having a wet seal |
| 02/01/2007 | US20070026091 Preparation and Administration of Jojoba Product for Reducing Weight, Fat and Blood Lipid Levels and for the Prevention and Treatment of Cancer |
| 02/01/2007 | US20070026087 Anti-coronavirus agent |
| 02/01/2007 | US20070026083 Method to improve characteristics of spray dried powders and granulated materials, and the products thereby produced |
| 02/01/2007 | US20070026082 Multiparticle pharmaceutical dosage form containing a mucoadhesively formulated peptide or protein active substances method for producing said pharmaceutical dosage form |
| 02/01/2007 | US20070026081 Microparticles |
| 02/01/2007 | US20070026080 Manufacturing process for tigecycline |
| 02/01/2007 | US20070026079 Intranasal administration of modulators of hypothalamic ATP-sensitive potassium channels |
| 02/01/2007 | US20070026078 Pharmaceutical co-crystal compositions |
| 02/01/2007 | US20070026077 Method of producing dosage units of a solid drug form containing warfarin sodium salt as active component |
| 02/01/2007 | US20070026076 Molecular vaccines employing nucleic acid encoding anti-apoptotic proteins |
| 02/01/2007 | US20070026075 Gelled donepezil compositions and methods for making and using the same |
| 02/01/2007 | US20070026074 rapidly forms a gel when in contact with sodium or calcium cations in the body for prolonged release of a therapeutic agent; low acyl gellan gum and a phenolic acid; no leakage; antibiotics, fungicides |
| 02/01/2007 | US20070026073 Amorphous efavirenz and the production thereof |
| 02/01/2007 | US20070026072 Benzoquinones of enhanced bioavailability |
| 02/01/2007 | US20070026071 Magnesium salt proton pump inhibitor dosage forms |
| 02/01/2007 | US20070026070 Cross-linked polysaccharide composition |
| 02/01/2007 | US20070026069 Biommetic hierarchies using functionalized nanoparticles as building blocks |
| 02/01/2007 | US20070026068 Compartmentalized dosage form |
| 02/01/2007 | US20070026067 Liquid formulations for controlled delivery of benzisoxazole derivatives |
| 02/01/2007 | US20070026066 Oral pharmaceutical delivery system with improved sustained release |
| 02/01/2007 | US20070026065 Solid, modified-release pharmaceutical dosage forms which can be administered orally |
| 02/01/2007 | US20070026064 Pharmaceutical dosage forms having watermark-type identification and authentication inditia |
| 02/01/2007 | US20070026063 Composition for coating comprising low-substituted cellulose ether and coated preparation having unpleasant taste masked |
| 02/01/2007 | US20070026062 Gemfibrozil, fenofibrate, bezafibrate, clofibrate, ciprofibrate and active metabolites and analogues dissolved in a vehicle, which is hydrophobic, hydrophilic or water-miscible; improved bioavailability of the active ingredient upon oral administration; administered to the patient in fed or fasted state |
| 02/01/2007 | US20070026061 Liposomal formulation and use thereof |
| 02/01/2007 | US20070026060 Method for treating advanced ovarian cancer |
| 02/01/2007 | US20070026059 Ligands for orphan nuclear hormone receptor steroidogenic factor-1 (SF-1) |
| 02/01/2007 | US20070026058 Method and composition for treating rhinitis |
| 02/01/2007 | US20070026057 In vivo targeting of dendritic cells |
| 02/01/2007 | US20070026056 Antiviral patch |
| 02/01/2007 | US20070026055 Production method of nicotine transdermal preparation |
| 02/01/2007 | US20070026054 Medicament preparations for transdermal application containing active ingredient combinations for treating parkinson's disease |
| 02/01/2007 | US20070026053 Joint resurfacing orthopaedic implant and associated method |